Try it
PSM · HIV: post-exposure prophylaxis
Sample itemA 25-year-old nurse sustains a deep needle-stick injury from a patient known to be HIV positive and presents 10 hours later. Her baseline HIV test is negative. Which post-exposure prophylaxis is appropriate under the national programme?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Tenofovir, lamivudine and dolutegravir for 28 days
Post-exposure prophylaxis should start as soon as possible, ideally within 2 hours and no later than 72 hours after a significant exposure. A three-drug regimen containing tenofovir, lamivudine and dolutegravir is given for 28 days, with baseline and follow-up testing. Single-drug or shortened courses are inadequate.
Option by option
A. A single dose of nevirapine
Single-dose nevirapine is used to reduce mother-to-child transmission historically, not for occupational prophylaxis.
B. Zidovudine alone for 28 days
Monotherapy is not adequate and is an obsolete approach.
C. Tenofovir, lamivudine and dolutegravir for 28 days (correct)
A three-drug fixed-dose regimen for the full 28 days is the standard for a significant exposure.
D. Tenofovir, lamivudine and dolutegravir for 7 days
Seven days is too short to ensure the prevention of establishment of infection.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: